79382468

Information

  • Trademark
  • 79382468
  • Serial Number
    79382468
  • Filing Date
    June 22, 2023
    a year ago
  • Transaction Date
    September 25, 2024
    3 months ago
  • Status Date
    September 25, 2024
    3 months ago
  • Location Date
    September 25, 2024
    3 months ago
  • Status Code
    661
  • Current Location
    TMO LAW OFFICE 121 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    OSGOOD, KRYSTINA
  • Attorney Name
    Catherine Fran Hoffman
    Law Office Assigned Location Code
    N30
  • Owners
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of The mark consists of a broken hexagon design with four shaded lines within the hexagon, two of the lines connected to the left side of the hexagon.
  • GS0051: Pharmaceuticals for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases; more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen, namely viral, bacterial, fungal or parasitic infections and pathogen-caused diseases, namely respiratory system diseases, such as viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases; digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections, muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders; skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; Pharmaceutical drugs, namely, drugs for immunization and/or prevention or treatment of diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases; more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic. infections and pathogen-caused diseases such as respiratory system diseases such as viral induced asthma, congenital diseases, autoimmune diseases; immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases; urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections, muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders; skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections; endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders; metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders; ocular diseases, such as glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections; hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; Dermatological pharmaceutical products, namely pharmaceuticals for the prevention, treatment, or management of dermatological conditions, including: skin infections, such as bacterial, viral, fungal, or parasitic infections; inflammatory skin diseases, including psoriasis, eczema, dermatitis, and rosacea; acne and acne-related disorders, including comedonal acne, inflammatory acne, and nodulocystic acne; pigmentation disorders, such as melasma, vitiligo, and post-inflammatory hyperpigmentation, skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma; hair and scalp conditions, such as alopecia, dandruff, and seborrheic dermatitis; nail disorders, including onychomycosis, nail psoriasis, and paronychia, wound care and healing products, such as those for diabetic ulcers, pressure ulcers, and surgical wounds; cosmetic dermatology treatments, including anti-aging treatments, skin rejuvenation, and scar reduction; products for sun protection and photodamage, such as sunscreens, photoprotective agents, and treatments for sunburn, treatments for skin allergies, such as urticaria, contact dermatitis, and drug-induced skin reactions, skin hydration and barrier repair products, including emollients, moisturizers, and barrier creams, products for rare dermatological diseases, such as epidermolysis bullosa, ichthyosis, and pemphigus vulgaris; products for cellulite reduction, stretch marks, and skin tightening; palliative care for skin conditions, such as pain management, itch relief, and symptomatic care for chronic skin diseases; Pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases; more specifically lung viral diseases, lung ciliopathies and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases and viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases; nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases; digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases; urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections; reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections; muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases; tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders; skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration, and ocular infections, ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections; hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; dermatological pharmaceutical products; Pharmaceutical compositions, namely pharmaceuticals for the treatment of pharmaceutical preparations for the treatment and/or prevention of diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases, and viral induced asthma, congenital diseases such as primary ciliary dyskinesia, autoimmune diseases, immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections; muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders, bone fracture; skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration, and ocular infections, ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections; hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; antidiabetic pharmaceuticals; anti-diabetic pharmaceuticals; cardiovascular pharmaceuticals; Injectable pharmaceuticals for treatment and/or prevention of diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases, such as viral induced asthma, congenital diseases such as primary ciliary dyskinesia, autoimmune diseases,immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections, muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes; lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections; hematologic diseases, such as anemia, hemophilia, and clotting disorders; cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; Tissue-regenerative pharmaceutical preparations for the treatment of conditions affecting the respiratory system, such as lung tissue repair, airway regeneration, and recovery from lung fibrosis, skin and mucosal tissues, including wound healing, burns, ulcers, surgical wounds, diabetic foot ulcers, pressure sores, oral mucositis, and mucosal lesions, bone regeneration, such as in cases of fractures, osteoporosis, bone grafts, and bone defects, dental applications, including regeneration of teeth, periodontal tissues, dental pulp, and treatment of alveolar bone loss, circulatory system conditions, such as heart tissue repair after myocardial infarction, ischemic injury, heart failure, arterial and venous regeneration, treatment of peripheral artery disease, and vascular grafts; regeneration of soft tissues, including tendons, ligaments and cartilage; treatment of nerve injuries, including peripheral nerve regeneration and spinal cord injury repair, treatment of muscle injuries, such as muscular dystrophies, myopathies, and muscle atrophy; applications in organ repair and regeneration, including liver regeneration, kidney regeneration, and intestinal tissue repair, ophthalmic regeneration, such as corneal repair, retinal regeneration, and treatment of ocular surface diseases, regenerative treatments for reproductive tissues, such as uterine or ovarian tissue regeneration, and treatment of rare diseases involving tissue degeneration or defects, such as epidermolysis bullosa, osteogenesis imperfecta, and amyotrophic lateral sclerosis (ALS); cardiovascular pharmaceutical preparations; antibacterial pharmaceuticals; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; anaesthetic preparations for inhalation; pharmaceutical preparations for inhalers for the treatment of respiratory diseases and disorders; Sanitary preparations and articles, namely disinfectants and antiseptics for skin and surfaces, antimicrobial hand sanitizers, antimicrobial wipes, wound cleansing solutions and sprays, barrier creams and lotions for skin protection, LNP-enhanced wound dressings, sterile bandages and gauze infused with regenerative agents, sanitizing sprays for medical devices and equipment, nasal sprays for decontamination, treatment and pathogen prevention, oral hygiene products such as mouth rinses and gels, eye drops for sterile cleansing and infection prevention, personal hygiene products like feminine hygiene sprays, LNP-enhanced protective masks and filters, air purifying sprays and filters, pre-surgical skin preparation solutions, LNP-based decontaminating agents for burns and cuts, sanitizing gels and creams for dermatitis and skin conditions, sanitizing agents for public health emergencies, foot and nail fungal treatment sprays, surface sanitizers for household and industrial use; air deodorising and air purifying preparations; Hygienic preparations and articles, namely: aerosol sprays for respiratory lung disease management, such as antiviral and antibacterial aerosol sprays for upper and lower respiratory tract protection, mucolytic sprays to break down mucus and improve airflow, LNP-enhanced nasal mRNA expression sprays, aerosolized vaccines for respiratory pathogens, such as influenza or COVID-19,inhalable sprays containing nanocarriers, aerosol sprays for chronic obstructive pulmonary disease (COPD) management, including treatments for bronchitis and emphysema, immune-boosting sprays for respiratory health maintenance, sprays delivering regenerative agents for lung tissue repair and fibrosis treatment, inhalable sprays with LNPs targeting primary ciliary dyskinesia, cystic fibrosis or other genetic lung disorders; pulmonary delivery systems for managing asthma, including rescue and maintenance therapies, aerosolized sprays with nanoparticle-based antibiotics or antivirals for treating bacterial or viral lung infections, LNP-based sprays for preventing and managing acute respiratory distress syndrome (ARDS), inhalable sprays for reducing pulmonary inflammation and oxidative stress, sprays for localized drug delivery to specific areas of the respiratory tract, prophylactic sprays for occupational lung disease prevention, inhalable agents for managing smoke inhalation injury or pollution-related respiratory damage, and LNP-based sprays for targeted delivery of gene therapies or RNA-based treatments for lung diseases; Dental preparations for regeneration of teeth, periodontal tissues, dental pulp, and treatment of alveolar bone loss; dental articles, namely, materials for tooth restoration, dental cements, dental filling materials, bone fillers consisting of living materials and bone growth media consisting of biological materials for medical purposes; medicated dentifrices; dietary supplements and dietetic preparations adapted for medical purposes; Pest control preparations and articles, namely, insect repellent preparations, insecticides, acaricides; pharmaceutical preparations for the treatment of kidney diseases; respiratory stimulants; compounds, namely, pharmaceutical preparations for treating correlated pulmonary syndromes; medicines for the treatment of cardiovascular and cerebrovascular diseases; fertility enhancement preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for the prevention of disorders of the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune disorders; autoantigens, namely, pharmaceutical preparations for the treatment and prevention of human autoimmune diseases and cancer; vaccines; vaccine preparations; vaccine adjuvants; Veterinary vaccines for animals, such as bovine, caprine, sheep, horse, poultry, cat and dog; vaccines against pneumococcal infections; viral vaccines; human vaccine preparations; vaccines against flu; oral vaccine preparations; Antiviral drugs being antivirals for treating influenza; vaccines for human use; Fat emulsions, namely, formulations comprising nucleic acids and/or nanocarriers such as lipid nanoparticles for medical infusions; Medical preparations, namely medical preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations, aerosols formulations, spray formulations; Medicinal healthcare preparations namely preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations, aerosols formulations, spray formulations; Medicinal infusions for treating diseases and conditions affecting various body systems, including, respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases such as viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections; muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders; skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections; endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration, and ocular infections, ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; Infusions, namely, medicinal infusions for treating diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases; more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases, viral induced asthma, congenital diseases; autoimmune diseases; immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies,, circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases; urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections; muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders; bone fracture, skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders; ocular diseases, such as glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections; hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; Medicinal preparations and substances, namely preparations comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations; Medicine for diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases; more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases such as viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies; circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections, muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders; ocular diseases, such as glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections; hematologic diseases, such as anemia, hemophilia, and clotting disorders; cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; Serotherapeutic medicines for: passive immunity, modulating immune responses, convalescent plasma therapies, treating autoimmune diseases, inflammatory conditions, cancer, viral infections, and preventing or treating allergic reactions; antiallergic medicines; Medicines for animals, namely, medicine for diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases; more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases such as viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections; muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, bone diseases, such as osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections; endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes; lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration and ocular infections, ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; nucleic acid sequences for medical and veterinary purposes; Acids for pharmaceutical purposes, namely nucleic acids, recombinant nucleic acids, fatty acid esters, phospholipids, Ionizable Lipids, cholesterol derivative acids; adjuvants for medical purposes; cellular function activating agents for medical purposes; Chemical preparations for medical purposes, namely, for diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases; pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases such as viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections; muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, teeth diseases and decay, and bone metabolic disorders, bone fracture; skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections; endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions including treatments for aesthetic improvement, skin rejuvenation, and hair restoration; palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; chemical preparations for veterinary purposes for the treatment of diseases and conditions affecting various body systems, including: respiratory system diseases, such as lung diseases, airway diseases, or nasal diseases, more specifically lung viral diseases, lung ciliopathies, and lung autoimmune diseases, pathogen such as viral, bacterial, fungal or parasitic, infections and pathogen-caused diseases such as respiratory system diseases and viral induced asthma, congenital diseases, autoimmune diseases, immune system diseases, nervous system diseases, including neurodegenerative diseases, neuroinflammatory diseases, and neuropathies, circulatory system diseases, such as cardiovascular diseases, blood disorders, and vascular diseases, digestive system diseases, including gastrointestinal diseases, liver diseases, and pancreatic diseases, urinary system diseases, such as kidney diseases, bladder disorders, and urinary tract infections, reproductive system diseases, including infertility, hormonal disorders, and reproductive tract infections, muscular diseases, including muscular dystrophies, myopathies, and inflammatory muscle diseases, tendon diseases, bone diseases, such as osteoporosis, osteoarthritis, bone fracture, teeth diseases and decay, and bone metabolic disorders, skin diseases, including dermatological conditions, inflammatory skin diseases, and skin infections, endocrine system diseases, such as diabetes, thyroid disorders, and adrenal gland disorders, metabolic diseases, including genetic metabolic disorders and acquired metabolic syndromes, lymphatic system diseases, such as lymphedema and lymphatic infections, psychiatric and mental health conditions, including mood disorders, anxiety disorders, and psychotic disorders, ocular diseases, such as glaucoma, macular degeneration, and ocular infections; ear, nose, and throat (ENT) diseases, including rhinitis, sinusitis, otitis, and throat infections, hematologic diseases, such as anemia, hemophilia, and clotting disorders, cosmetic conditions, including treatments for aesthetic improvement, skin rejuvenation, and hair restoration, palliative care conditions, such as pain management and supportive care for chronic or terminal illnesses; nasal sprays for medical purposes; medicated nasal spray preparations; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; Compounds being pharmaceutical preparations for treating cancer; pharmaceutical preparations for activating cellular function
  • GS0011: Preservatives for pharmaceuticals; chemicals for use in industry and science; chemical substances, namely, chemical reagents used in the manufacture of biological preparations and preparation comprising nucleic acids and nanocarriers or nanoparticles; biological preparations regarding use in industry and science; nucleic acids and organic chemicals for use in industry and science, other than for medical or veterinary purposes; industrial organic chemicals; organic chemicals used in the industry; detergents for use in manufacture of nanocarriers or nanoparticles and its formulations, formulations comprising nucleuic acids, detergents for use in manufacturing processes in the industry; salts for industrial purposes; chemicals and organic compositions being organic chemicals for use in the manufacture of food and beverages; Aqueous chemical compositions, namely, compositions comprising nucleic acids and nanocarriers or nanoparticles and its formulations; Triglycerides being chemical additives for use in the manufacture of medicines, medical formulations and medicines comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations; triglycerides being chemical additives for use in the manufacture of food; nucleic recombinant acids for scientific purposes; nucleic acids, other than for medical or veterinary purposes; nucleic acids for scientific purposes; pyrimidine; Lipids for use in manufacture of medicines or pharmaceutical formulations, namely, medicines comprising nucleic acids and/or nanocarriers or nanoparticles and its formulations; Hydrosoluble polymers for use in medicines and/or pharmaceutical formulations; Polymer dispersions for use in medicines and/or pharmaceutical formulations; biodegradable polymer compositions used in the manufacture of commercial and industrial goods, such as medicines and/or pharmaceutical formulations; Hydrogel polymer coating for use in medicines and/or pharmaceutical formulations; Cationic polymers for use in medicines and/or pharmaceutical formulations; polymer solutions for use in or such as medicines and/or pharmaceutical formulations; Aqueous polymer dispersions for use in medicines and/or pharmaceutical formulations; polymer solutions for use in or such as medicines and/or pharmaceutical formulations; Fatty acid esters for use in medicines and/or pharmaceutical formulations
  • GS0441: Preparation and dispensing of medications; human fertility treatment; human fertility treatment services; Vaccination services, namely, administering vaccines to patients, preparation of vaccine and vaccination material, testing of vaccines; regenerative medicine services; dispensing of pharmaceuticals
  • GS0421: Research on the subject of pharmaceuticals; ; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; vaccine research and development services; research and development services relating to vaccines; development of gene-based medicines; gene therapy research; research in the field of gene therapy; laboratory research in the field of gene expression; research in the field of gene editing technology; research and development services in the field of gene expression systems; advisory services relating to gene therapy research; biotechnology research; research and development in the pharmaceutical and biotechnology fields; Biotechnology testing, namely, product testing for others, such as nucleic acids testing, nanocarrier testing, aerosol testing, vaccine testing; scientific research relating to biology; scientific research in the field of genetics and genetic engineering; animal genetics research; scientific research relating to molecular sciences; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research in the field of genetics; scientific research relating to genetics
Case File Event Statements
  • 3/11/2024 - 9 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/2/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/6/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/10/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/11/2024 - 9 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/12/2024 - 9 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/30/2024 - 9 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/30/2024 - 9 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 9/24/2024 - 3 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/24/2024 - 3 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/25/2024 - 3 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/24/2024 - 8 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT